[NH:1](C(OC(C)(C)C)=O)[C@H:2]([C:8]([O:10]C(C)(C)C)=[O:9])[CH2:3][CH2:4][C:5](=O)[OH:6].CN(C(ON1N=NC2C=CC=NC1=2)=[N+](C)C)C.F[P-](F)(F)(F)(F)F.C1C=NC2N(O)N=NC=2C=1.[NH2:56][C:57]1[C:58]([OH:68])=[C:59]([S:64]([OH:67])(=[O:66])=[O:65])[CH:60]=[C:61]([Cl:63])[CH:62]=1>CN(C=O)C.C(O)(C(F)(F)F)=O.N1C=CC=CC=1>[NH2:1][C@@H:2]([CH2:3][CH2:4][C:5](=[O:6])[NH:56][C:57]1[CH:62]=[C:61]([Cl:63])[CH:60]=[C:59]([S:64]([OH:67])(=[O:66])=[O:65])[C:58]=1[OH:68])[C:8]([OH:10])=[O:9]101 mg (0.33 mmol) of Boc-Glu-OtBu, 130 mg (0.33 mmol) of HATU, 45 mg (0.33 mmol) of HOAt and 77 mg (0.33 mmol) of 3-amino-5-chloro-2-hydroxybenzenesulfonic acid were suspended in 2.0 ml of DMF, to which 0.5 ml of pyridine was added and stirred at room temperature overnight. After distilling the solvent away, purification step A was used to obtain an intermediate. This crude product was dissolved in 2.0 ml of TFA and stirred at room temperature for 90 minutes. After distilling the solvent away, purification step A was used to obtain the title compound.